Your portfolio, defensible.
One brief per grantee. Cited. Approved. Updated.
For the funder asking what changed and why — with every claim cited.
One brief per grantee. Cited. Approved. Updated.
Drop in your numbers. movó drafts the funder brief. Your team approves.
Embed a fractional Chief Continuity Officer in 14 days. The team leads each engagement together.
Click any tab. Click anything inside the sample. The screen updates with the cited evidence behind that view. No static screenshots.
Your morning brief, ready before the first meeting.
Active PrEP users now total 77 (45 oral + 32 long-acting injectable), reaching 257% of the 2026 goal of 30. Lead the Gilead renewal call with this line; injectable capacity is the ask.
movó is operating intelligence for any organization whose next decision must survive scrutiny — from community-rooted programs and the funders who back them to enterprises managing portfolios, advisors running diagnostics, and any team where 'we believe' needs to become 'here's the cited proof.'